BioCentury
ARTICLE | Company News

Takeda infectious news

September 13, 2010 7:00 AM UTC

Japan's Pharmaceutical Development Support Center awarded Takeda ¥3.6 billion ($42.8 million) for a cell culture-based influenza development project. Takeda will use Vero cell culture technology from ...